APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyprogesterone Caproate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydroxyprogesterone Caproate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchHydroxyprogesterone Caproate Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyprogesterone Caproate Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Hydroxyprogesterone Caproate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyprogesterone Caproate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyprogesterone Caproate Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Hydroxyprogesterone Caproate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydroxyprogesterone Caproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxyprogesterone Caproate include Zhejiang Xianju Pharmaceutical, Mylan Institutional, Upjohn Co, Symbiotec Pharmalab, Sun Pharmaceutical, Steroid Spa, Schering Ag, Naari Ag and Mcguff Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxyprogesterone Caproate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxyprogesterone Caproate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyprogesterone Caproate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyprogesterone Caproate market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyprogesterone Caproate Segment by Company

Zhejiang Xianju Pharmaceutical

Mylan Institutional

Upjohn Co

Symbiotec Pharmalab

Sun Pharmaceutical

Steroid Spa

Schering Ag

Naari Ag

Mcguff Pharmaceuticals Inc

Diosynth Bv

Aspen Oss B.V.

Antibioticos Spa

ANI Pharmaceuticals, Inc.

AMAG Pharmaceuticals

Hydroxyprogesterone Caproate Segment by Type

1 mL Injection(Including 1.1 mL)

5 mL Injection

Hydroxyprogesterone Caproate Segment by Application

Hospitals Injection

Clinics Injection

Hydroxyprogesterone Caproate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyprogesterone Caproate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxyprogesterone Caproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxyprogesterone Caproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxyprogesterone Caproate Industry Trends Table 2. Hydroxyprogesterone Caproate Industry Drivers Table 3. Hydroxyprogesterone Caproate Industry Opportunities and Challenges Table 4. Hydroxyprogesterone Caproate Industry Restraints Table 5. Global Hydroxyprogesterone Caproate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxyprogesterone Caproate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxyprogesterone Caproate Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Hydroxyprogesterone Caproate Sales Market Share by Manufacturers Table 9. Global Hydroxyprogesterone Caproate Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Hydroxyprogesterone Caproate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxyprogesterone Caproate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxyprogesterone Caproate Manufacturers, Product Type & Application Table 13. Global Hydroxyprogesterone Caproate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyprogesterone Caproate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1 mL Injection(Including 1.1 mL) Table 17. Major Manufacturers of 5 mL Injection Table 18. Global Hydroxyprogesterone Caproate Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 19. Global Hydroxyprogesterone Caproate Sales by Type (2021-2026) & (W Tons) Table 20. Global Hydroxyprogesterone Caproate Sales by Type (2027-2032) & (W Tons) Table 21. Global Hydroxyprogesterone Caproate Sales Market Share by Type (2021-2026) Table 22. Global Hydroxyprogesterone Caproate Sales Market Share by Type (2027-2032) Table 23. Global Hydroxyprogesterone Caproate Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 24. Global Hydroxyprogesterone Caproate Revenue by Type (2021-2026) & (W Tons) Table 25. Global Hydroxyprogesterone Caproate Revenue by Type (2027-2032) & (W Tons) Table 26. Global Hydroxyprogesterone Caproate Revenue Market Share by Type (2021-2026) Table 27. Global Hydroxyprogesterone Caproate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Injection Table 29. Major Manufacturers of Clinics Injection Table 30. Global Hydroxyprogesterone Caproate Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 31. Global Hydroxyprogesterone Caproate Sales by Application (2021-2026) & (W Tons) Table 32. Global Hydroxyprogesterone Caproate Sales by Application (2027-2032) & (W Tons) Table 33. Global Hydroxyprogesterone Caproate Sales Market Share by Application (2021-2026) Table 34. Global Hydroxyprogesterone Caproate Sales Market Share by Application (2027-2032) Table 35. Global Hydroxyprogesterone Caproate Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 36. Global Hydroxyprogesterone Caproate Revenue by Application (2021-2026) & (W Tons) Table 37. Global Hydroxyprogesterone Caproate Revenue by Application (2027-2032) & (W Tons) Table 38. Global Hydroxyprogesterone Caproate Revenue Market Share by Application (2021-2026) Table 39. Global Hydroxyprogesterone Caproate Revenue Market Share by Application (2027-2032) Table 40. Global Hydroxyprogesterone Caproate Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 41. Global Hydroxyprogesterone Caproate Sales by Region (2021-2026) & (W Tons) Table 42. Global Hydroxyprogesterone Caproate Sales Market Share by Region (2021-2026) Table 43. Global Hydroxyprogesterone Caproate Sales Forecasted by Region (2027-2032) & (W Tons) Table 44. Global Hydroxyprogesterone Caproate Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 46. North America Hydroxyprogesterone Caproate Sales by Country (2021-2026) & (W Tons) Table 47. North America Hydroxyprogesterone Caproate Sales by Country (2027-2032) & (W Tons) Table 48. Europe Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 49. Europe Hydroxyprogesterone Caproate Sales by Country (2021-2026) & (W Tons) Table 50. Europe Hydroxyprogesterone Caproate Sales by Country (2027-2032) & (W Tons) Table 51. Asia Pacific Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 52. Asia Pacific Hydroxyprogesterone Caproate Sales by Country (2021-2026) & (W Tons) Table 53. Asia Pacific Hydroxyprogesterone Caproate Sales by Country (2027-2032) & (W Tons) Table 54. South America, Middle East and Africa Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 55. South America, Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2021-2026) & (W Tons) Table 56. South America, Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2027-2032) & (W Tons) Table 57. Global Hydroxyprogesterone Caproate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hydroxyprogesterone Caproate Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hydroxyprogesterone Caproate Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hydroxyprogesterone Caproate Revenue Market Share by Region (2021-2026) Table 61. Global Hydroxyprogesterone Caproate Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Xianju Pharmaceutical Company Information Table 63. Zhejiang Xianju Pharmaceutical Business Overview Table 64. Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio Table 66. Zhejiang Xianju Pharmaceutical Recent Development Table 67. Mylan Institutional Company Information Table 68. Mylan Institutional Business Overview Table 69. Mylan Institutional Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Mylan Institutional Hydroxyprogesterone Caproate Product Portfolio Table 71. Mylan Institutional Recent Development Table 72. Upjohn Co Company Information Table 73. Upjohn Co Business Overview Table 74. Upjohn Co Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Upjohn Co Hydroxyprogesterone Caproate Product Portfolio Table 76. Upjohn Co Recent Development Table 77. Symbiotec Pharmalab Company Information Table 78. Symbiotec Pharmalab Business Overview Table 79. Symbiotec Pharmalab Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Symbiotec Pharmalab Hydroxyprogesterone Caproate Product Portfolio Table 81. Symbiotec Pharmalab Recent Development Table 82. Sun Pharmaceutical Company Information Table 83. Sun Pharmaceutical Business Overview Table 84. Sun Pharmaceutical Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sun Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio Table 86. Sun Pharmaceutical Recent Development Table 87. Steroid Spa Company Information Table 88. Steroid Spa Business Overview Table 89. Steroid Spa Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Steroid Spa Hydroxyprogesterone Caproate Product Portfolio Table 91. Steroid Spa Recent Development Table 92. Schering Ag Company Information Table 93. Schering Ag Business Overview Table 94. Schering Ag Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Schering Ag Hydroxyprogesterone Caproate Product Portfolio Table 96. Schering Ag Recent Development Table 97. Naari Ag Company Information Table 98. Naari Ag Business Overview Table 99. Naari Ag Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Naari Ag Hydroxyprogesterone Caproate Product Portfolio Table 101. Naari Ag Recent Development Table 102. Mcguff Pharmaceuticals Inc Company Information Table 103. Mcguff Pharmaceuticals Inc Business Overview Table 104. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Product Portfolio Table 106. Mcguff Pharmaceuticals Inc Recent Development Table 107. Diosynth Bv Company Information Table 108. Diosynth Bv Business Overview Table 109. Diosynth Bv Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Diosynth Bv Hydroxyprogesterone Caproate Product Portfolio Table 111. Diosynth Bv Recent Development Table 112. Aspen Oss B.V. Company Information Table 113. Aspen Oss B.V. Business Overview Table 114. Aspen Oss B.V. Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Aspen Oss B.V. Hydroxyprogesterone Caproate Product Portfolio Table 116. Aspen Oss B.V. Recent Development Table 117. Antibioticos Spa Company Information Table 118. Antibioticos Spa Business Overview Table 119. Antibioticos Spa Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Antibioticos Spa Hydroxyprogesterone Caproate Product Portfolio Table 121. Antibioticos Spa Recent Development Table 122. ANI Pharmaceuticals, Inc. Company Information Table 123. ANI Pharmaceuticals, Inc. Business Overview Table 124. ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Product Portfolio Table 126. ANI Pharmaceuticals, Inc. Recent Development Table 127. AMAG Pharmaceuticals Company Information Table 128. AMAG Pharmaceuticals Business Overview Table 129. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Product Portfolio Table 131. AMAG Pharmaceuticals Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Hydroxyprogesterone Caproate Distributors List Table 135. Hydroxyprogesterone Caproate Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Hydroxyprogesterone Caproate Product Image Figure 2. Global Hydroxyprogesterone Caproate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyprogesterone Caproate Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyprogesterone Caproate Sales (2021-2032) & (W Tons) Figure 5. Global Hydroxyprogesterone Caproate Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxyprogesterone Caproate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1 mL Injection(Including 1.1 mL) Image Figure 9. 5 mL Injection Image Figure 10. Global Hydroxyprogesterone Caproate Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 11. Global Hydroxyprogesterone Caproate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydroxyprogesterone Caproate Sales Market Share by Type (2021-2032) Figure 13. Global Hydroxyprogesterone Caproate Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 14. Global Hydroxyprogesterone Caproate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydroxyprogesterone Caproate Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Injection Image Figure 17. Clinics Injection Image Figure 18. Global Hydroxyprogesterone Caproate Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 19. Global Hydroxyprogesterone Caproate Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hydroxyprogesterone Caproate Sales Market Share by Application (2021-2032) Figure 21. Global Hydroxyprogesterone Caproate Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 22. Global Hydroxyprogesterone Caproate Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydroxyprogesterone Caproate Revenue Market Share by Application (2021-2032) Figure 24. North America Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 25. North America Hydroxyprogesterone Caproate Sales Market Share by Country (2021-2032) Figure 26. U.S. Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. Canada Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 28. Mexico Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Europe Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Europe Hydroxyprogesterone Caproate Sales Market Share by Country (2021-2032) Figure 31. Germany Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. France Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 33. U.K. Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. Italy Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. Netherlands Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Asia Pacific Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Asia Pacific Hydroxyprogesterone Caproate Sales Market Share by Country (2021-2032) Figure 38. China Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Japan Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 40. South Korea Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Southeast Asia Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. India Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Australia Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. South America, Middle East and Africa Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. South America, Middle East and Africa Hydroxyprogesterone Caproate Sales Market Share by Country (2021-2032) Figure 46. Brazil Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South Africa Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 48. Saudi Arabia Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. Turkey Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Argentina Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. UAE Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Egypt Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. Chile Hydroxyprogesterone Caproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Global Hydroxyprogesterone Caproate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hydroxyprogesterone Caproate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hydroxyprogesterone Caproate Revenue (2021-2032) & (US$ Million) Figure 57. North America Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hydroxyprogesterone Caproate Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hydroxyprogesterone Caproate Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hydroxyprogesterone Caproate Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hydroxyprogesterone Caproate Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hydroxyprogesterone Caproate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Applications
  • Hospitals Injection
  • Clinics Injection
Companies covered
  • Zhejiang Xianju Pharmaceutical
  • Mylan Institutional
  • Upjohn Co
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Steroid Spa
  • Schering Ag
  • Naari Ag
  • Mcguff Pharmaceuticals Inc
  • Diosynth Bv
  • Aspen Oss B.V.
  • Antibioticos Spa
  • ANI Pharmaceuticals, Inc.
  • AMAG Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxyprogesterone Caproate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxyprogesterone Caproate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxyprogesterone Caproate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxyprogesterone Caproate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxyprogesterone Caproate Market Dynamics
  1. 2.1 Hydroxyprogesterone Caproate Industry Trends
  2. 2.2 Hydroxyprogesterone Caproate Industry Drivers
  3. 2.3 Hydroxyprogesterone Caproate Industry Opportunities and Challenges
  4. 2.4 Hydroxyprogesterone Caproate Industry Restraints
3 Hydroxyprogesterone Caproate Market by Manufacturers
  1. 3.1 Global Hydroxyprogesterone Caproate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxyprogesterone Caproate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxyprogesterone Caproate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxyprogesterone Caproate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyprogesterone Caproate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxyprogesterone Caproate Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxyprogesterone Caproate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyprogesterone Caproate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyprogesterone Caproate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyprogesterone Caproate Tier 1, Tier 2, and Tier 3
4 Hydroxyprogesterone Caproate Market by Type
  1. 4.1 Hydroxyprogesterone Caproate Type Introduction
  2. 4.1.1 1 mL Injection(Including 1.1 mL)
  3. 4.1.2 5 mL Injection
  4. 4.2 Global Hydroxyprogesterone Caproate Sales by Type
  5. 4.2.1 Global Hydroxyprogesterone Caproate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydroxyprogesterone Caproate Sales by Type (2021-2032)
  7. 4.2.3 Global Hydroxyprogesterone Caproate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydroxyprogesterone Caproate Revenue by Type
  9. 4.3.1 Global Hydroxyprogesterone Caproate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydroxyprogesterone Caproate Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydroxyprogesterone Caproate Revenue Market Share by Type (2021-2032)
5 Hydroxyprogesterone Caproate Market by Application
  1. 5.1 Hydroxyprogesterone Caproate Application Introduction
  2. 5.1.1 Hospitals Injection
  3. 5.1.2 Clinics Injection
  4. 5.2 Global Hydroxyprogesterone Caproate Sales by Application
  5. 5.2.1 Global Hydroxyprogesterone Caproate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyprogesterone Caproate Sales by Application (2021-2032)
  7. 5.2.3 Global Hydroxyprogesterone Caproate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydroxyprogesterone Caproate Revenue by Application
  9. 5.3.1 Global Hydroxyprogesterone Caproate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyprogesterone Caproate Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydroxyprogesterone Caproate Revenue Market Share by Application (2021-2032)
6 Global Hydroxyprogesterone Caproate Sales by Region
  1. 6.1 Global Hydroxyprogesterone Caproate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyprogesterone Caproate Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyprogesterone Caproate Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxyprogesterone Caproate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxyprogesterone Caproate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxyprogesterone Caproate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxyprogesterone Caproate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxyprogesterone Caproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxyprogesterone Caproate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxyprogesterone Caproate Revenue by Region
  1. 7.1 Global Hydroxyprogesterone Caproate Revenue by Region
  2. 7.1.1 Global Hydroxyprogesterone Caproate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxyprogesterone Caproate Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxyprogesterone Caproate Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxyprogesterone Caproate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxyprogesterone Caproate Revenue (2021-2032)
  8. 7.2.2 North America Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxyprogesterone Caproate Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxyprogesterone Caproate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxyprogesterone Caproate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxyprogesterone Caproate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
  7. 8.2 Mylan Institutional
  8. 8.2.1 Mylan Institutional Company Information
  9. 8.2.2 Mylan Institutional Business Overview
  10. 8.2.3 Mylan Institutional Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Institutional Hydroxyprogesterone Caproate Product Portfolio
  12. 8.2.5 Mylan Institutional Recent Developments
  13. 8.3 Upjohn Co
  14. 8.3.1 Upjohn Co Company Information
  15. 8.3.2 Upjohn Co Business Overview
  16. 8.3.3 Upjohn Co Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Upjohn Co Hydroxyprogesterone Caproate Product Portfolio
  18. 8.3.5 Upjohn Co Recent Developments
  19. 8.4 Symbiotec Pharmalab
  20. 8.4.1 Symbiotec Pharmalab Company Information
  21. 8.4.2 Symbiotec Pharmalab Business Overview
  22. 8.4.3 Symbiotec Pharmalab Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Symbiotec Pharmalab Hydroxyprogesterone Caproate Product Portfolio
  24. 8.4.5 Symbiotec Pharmalab Recent Developments
  25. 8.5 Sun Pharmaceutical
  26. 8.5.1 Sun Pharmaceutical Company Information
  27. 8.5.2 Sun Pharmaceutical Business Overview
  28. 8.5.3 Sun Pharmaceutical Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharmaceutical Hydroxyprogesterone Caproate Product Portfolio
  30. 8.5.5 Sun Pharmaceutical Recent Developments
  31. 8.6 Steroid Spa
  32. 8.6.1 Steroid Spa Company Information
  33. 8.6.2 Steroid Spa Business Overview
  34. 8.6.3 Steroid Spa Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Steroid Spa Hydroxyprogesterone Caproate Product Portfolio
  36. 8.6.5 Steroid Spa Recent Developments
  37. 8.7 Schering Ag
  38. 8.7.1 Schering Ag Company Information
  39. 8.7.2 Schering Ag Business Overview
  40. 8.7.3 Schering Ag Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Schering Ag Hydroxyprogesterone Caproate Product Portfolio
  42. 8.7.5 Schering Ag Recent Developments
  43. 8.8 Naari Ag
  44. 8.8.1 Naari Ag Company Information
  45. 8.8.2 Naari Ag Business Overview
  46. 8.8.3 Naari Ag Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Naari Ag Hydroxyprogesterone Caproate Product Portfolio
  48. 8.8.5 Naari Ag Recent Developments
  49. 8.9 Mcguff Pharmaceuticals Inc
  50. 8.9.1 Mcguff Pharmaceuticals Inc Company Information
  51. 8.9.2 Mcguff Pharmaceuticals Inc Business Overview
  52. 8.9.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Product Portfolio
  54. 8.9.5 Mcguff Pharmaceuticals Inc Recent Developments
  55. 8.10 Diosynth Bv
  56. 8.10.1 Diosynth Bv Company Information
  57. 8.10.2 Diosynth Bv Business Overview
  58. 8.10.3 Diosynth Bv Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Diosynth Bv Hydroxyprogesterone Caproate Product Portfolio
  60. 8.10.5 Diosynth Bv Recent Developments
  61. 8.11 Aspen Oss B.V.
  62. 8.11.1 Aspen Oss B.V. Company Information
  63. 8.11.2 Aspen Oss B.V. Business Overview
  64. 8.11.3 Aspen Oss B.V. Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aspen Oss B.V. Hydroxyprogesterone Caproate Product Portfolio
  66. 8.11.5 Aspen Oss B.V. Recent Developments
  67. 8.12 Antibioticos Spa
  68. 8.12.1 Antibioticos Spa Company Information
  69. 8.12.2 Antibioticos Spa Business Overview
  70. 8.12.3 Antibioticos Spa Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Antibioticos Spa Hydroxyprogesterone Caproate Product Portfolio
  72. 8.12.5 Antibioticos Spa Recent Developments
  73. 8.13 ANI Pharmaceuticals, Inc.
  74. 8.13.1 ANI Pharmaceuticals, Inc. Company Information
  75. 8.13.2 ANI Pharmaceuticals, Inc. Business Overview
  76. 8.13.3 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ANI Pharmaceuticals, Inc. Hydroxyprogesterone Caproate Product Portfolio
  78. 8.13.5 ANI Pharmaceuticals, Inc. Recent Developments
  79. 8.14 AMAG Pharmaceuticals
  80. 8.14.1 AMAG Pharmaceuticals Company Information
  81. 8.14.2 AMAG Pharmaceuticals Business Overview
  82. 8.14.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Product Portfolio
  84. 8.14.5 AMAG Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyprogesterone Caproate Value Chain Analysis
  2. 9.1.1 Hydroxyprogesterone Caproate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyprogesterone Caproate Production Mode & Process
  6. 9.2 Hydroxyprogesterone Caproate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyprogesterone Caproate Distributors
  9. 9.2.3 Hydroxyprogesterone Caproate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst